Clinic Trials Day at Royal BerksBy Laura McCardle
June 14, 2012
The treatment of severe sepsis (blood poisoning) and vasculitis are among more than 100 clinical trials being carried out by Royal Berkshire Hospital (RBH).
Staff marked International Clinical Trials Day by talking to patients and visitors about their role in helping pioneer new treatments.
The day is marked across the world on or near May 20, and RBH’s research and development (R&D) team marked it on Friday, May 18, by hosting an information and awareness day.
Dr Atul Kapila, R&D lead clinician, said: “We are very actively involved in research and it is from a more clinical point of view.
“At any given time there are over 100 clinical trials running here in the hospital over a wide range of specialities. They are primarily us trying to find better treatments or deciding between treatments.”
The team, along with consultants, spoke about some of the 145 clinical trials under way at the hospital, including those from the renal unit, emergency department and the intensive care unit (ICU).
Dr Oliver Flossman, a consultant in renal medicine, is leading work in the treatment of vasculitis, an inflammatory condition that destroys blood vessels.
He said: “I have trials which just look at understanding the disease, so that involves taking blood tests and detailed clinical examination.
“We have also taken part in a study that looks at the quality of life of the patients.”
The emergency department is carrying out a number of trials, including the treatment of severe sepsis, the practice of cooling patients who have suffered a cardiac arrest and the care of people suffering with a head injury who are regularly prescribed with blood thinning medication.
Consultant Dr Liza Keating said: “We’ve got about four or five studies on the go at the moment and it’s a new initiative within the trust – it’s brand new in the last year to have trials in the emergency department.”